Vulvar squamous cell carcinoma (VSCC), a rare gynecologic malignancy, has been rising in incidence. Molecular classification on the basis of human papilloma virus (HPV) and tumor protein 53 (p53) ...
Precision medicine is looking increasingly promising in advanced vulvar squamous cell carcinomas (VSCCs), which make up 90% of vulvar cancers. The emergence of molecular stratification provides ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
In a national retrospective cohort study in England, the incidence rate of vulval squamous cell carcinoma (VSCC) remained stable from 2013 to 2022, with diagnostic delays owing to poor awareness and ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
SCC is a common skin cancer, more aggressive than basal cell carcinoma, with potential to metastasize. Long-term UV exposure is a primary cause, with SCC often appearing on sun-exposed areas.
A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first ...
Gynecological cancers affect the reproductive organs of people who were assigned female at birth (AFAB). They include cancers of the: Cervix Ovaries Uterus Vagina Vulva A sixth type is a very rare ...
Patients enrolled in a single-arm phase II study. Pretreatment inguinal-femoral nodal assessment was performed. Sixty-four Gy IMRT was prescribed to the vulva, with 50-64 Gy delivered to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results